The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

ICUI

Concerning the House

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

United States · www.icumed.com

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$2.26B+16.8%
Gross profit$822.04M+14.8%
Operating income$22.82M-3.6%
Net income$732.00K-30.7%
Cash from ops$179.85M+9.1%
Quotation

$183.11

+3.77 (+2.1%)

52w hi$184.56
52w lo$111.90
Vol182.63K
As ofAug 13
The Verdict

Hold

Our score +0.24

Short+0.33
Medium+0.36
Long-0.20

computed 2026-08-13

By the Numbers

ICU Medical, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$4.58B
Enterprise value$5.47B
Trailing P/E155.18x
Forward P/E18.98x
EV / EBITDA15.85x
P / S (ttm)2.12x
Profit margin1.4%
Return on equity1.4%
Revenue growth+0.5%
Earnings growth-46.9%
Debt / equity59.82
Risk Metrics
Beta vs SPX1.06
Corr SPX0.45
Annual vol38.4%
Annual ret+16.9%
Sharpe0.44
Max DD-41.2%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental-0.03
Sector+0.12
Technical+0.23
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$180.22$183.37$178.79$183.11182.63K
Aug 12$180.31$181.05$177.02$179.34314.10K
Aug 11$182.42$185.30$181.62$182.08250.30K
Aug 10$182.67$186.17$180.89$182.42476.90K
Aug 7$182.35$192.85$180.88$184.56931.20K